HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sinemet and the treatment of Parkinsonism.

Abstract
Sinemet (a combination of levodopa with carbidopa, a dopa-decarboxylase inhibitor) has replaced levodopa for early treatment of parkinsonism. The blocking of the systemic uptake of dopamine has eliminated the previous complications of nausea, vomiting, and cardiac and respiratory arrhythmias; pyridoxine need not now be avoided. However, the earlier appearance of abnormal involuntary movements, hallucinations, occasional psychosis, and a dopa-resistant state limits treatment efficacy. In all-over experience the combination drug offers the best relief for rigidity and akinesia. It has improved the quality of life and reduced mortality by one half. The greatest benefits appear in the first 3 years; then complications set in. The relation of complications to dosage is now better understood, and the ratio of dopa-decarboxylase inhibitor to levodopa inhibitor to levodopa of 1:4 is better than the previous 1:10. Levodopa with or without dopa decarboxylase is not a cure for parkinsonism. Some agonist drugs (bromocryptine, lisuride) are showing promise in the testing stage. The evolving knowledge about neurotransmitters and peptide messengers offers hope for the growing number of patients with parkinsonism.
AuthorsB Boshes
JournalAnnals of internal medicine (Ann Intern Med) Vol. 94 Issue 3 Pg. 364-70 (Mar 1981) ISSN: 0003-4819 [Print] United States
PMID7013595 (Publication Type: Journal Article, Review)
Chemical References
  • Aromatic Amino Acid Decarboxylase Inhibitors
  • Drug Combinations
  • carbidopa, levodopa drug combination
  • Levodopa
  • Carbidopa
Topics
  • Aromatic Amino Acid Decarboxylase Inhibitors
  • Carbidopa (therapeutic use)
  • Chemical Phenomena
  • Chemistry
  • Drug Combinations (therapeutic use)
  • Follow-Up Studies
  • Humans
  • Levodopa (administration & dosage, adverse effects, therapeutic use)
  • Parkinson Disease (drug therapy)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: